Other

Retatrutide: Obesity drug opens to "compassionate use" in US after speculation Trump took it.

BMJ (Clinical research ed.) · 7 Aug 2026

Record

Publication details

Authors
Brown C
Journal
BMJ (Clinical research ed.)
Publication date
7 Aug 2026
Publication type
Journal Article
Evidence type
Other
Relevance classification
Primary
PubMed ID
42567543
DOI
10.1136/bmj-2026-100530
Language
eng
Linked clinical trial
Not reported

Abstract

Abstract not reported by the source record.

Weekly briefing

The Retatrutide Report

The most important retatrutide clinical trial, research and regulatory developments, once a week.

No spam. Unsubscribe anytime. By subscribing, you agree to receive the Retatrutide Report by email. You can unsubscribe at any time. Privacy Policy.